SIRT3 and breast cancer: Recently, several groups have provided evidence that SIRT3 is required to suppress tumorigenesis, and to induce stress-mediated cell death in tumors, including breast cancer, colorectal carcinoma, osteosarcoma, and leukemia [27-29,49,50].